Search Within

Genitourinary Oncology Service

  1. "Nature Reviews Clinical Oncology"
Formats
  1. Journal Article (7)
  2. Review (2)
  3. Editorial (1)
Groups
  1. Department of Medicine (10)
  2. Solid Tumor Oncology Division (10)
  3. GSK Faculty (3)
  4. Hematologic Malignancies, Division of (2)
  5. Hematology-Oncology Fellows (2)
  6. Human Oncology and Pathogenesis Program (2)

More Groups

People
  1. Howard Scher (5)
  2. Jonathan Rosenberg (3)
  3. Min Yuen Teo (2)
  4. Aphrothiti Hanrahan (1)
  5. David Aggen (1)
  6. David Solit (1)

More People

Years
  1. 2024 (2)
  2. 2019 (1)
  3. 2018 (1)
  4. 2017 (1)
  5. 2015 (1)
  6. 2014 (1)

More Years

Publications
  1. Nature Reviews Clinical Oncology (10)
Publishers
  1. Nature Publishing Group (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lighting the torch: intratumoural T cell-to-stroma enrichment score as a predictor of immunotherapy response in urothelial carcinoma
    Editorial

    Aggen, D. H.; Rosenberg, J. E.
    Nature Reviews Clinical Oncology (2024)

    Fulltext@MSK | Save
  • BRAF — A tumour-agnostic drug target with lineage-specific dependencies
    Review

    Hanrahan, A. J.; Chen, Z.; Rosen, N.; Solit, D. B.
    Nature Reviews Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Towards individualized therapy for metastatic renal cell carcinoma
    Review

    Kotecha, R. R.; Motzer, R. J.; Voss, M. H.
    Nature Reviews Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Drug development for noncastrate prostate cancer in a changed therapeutic landscape
    Journal Article

    Teo, M. Y.; O'Shaughnessy, M. J.; McBride, S. M.; Vargas, H. A.; Scher, H. I.
    Nature Reviews Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Systemic, perioperative management of muscle-invasive bladder cancer and future horizons
    Journal Article

    Funt, S. A.; Rosenberg, J. E.
    Nature Reviews Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Urological cancer: CHAARTED/GETUG 12-docetaxel in non-castrate prostate cancers
    Journal Article

    Teo, M. Y.; Scher, H. I.
    Nature Reviews Clinical Oncology (2015)

    Fulltext@MSK | Save
  • High-risk prostate cancer-classification and therapy
    Journal Article

    Chang, A. J.; Autio, K. A.; Roach, M.; Scher, H. I.
    Nature Reviews Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Molecular targets on the horizon for kidney and urothelial cancer
    Journal Article

    Bellmunt, J.; Teh, B. T.; Tortora, G.; Rosenberg, J. E.
    Nature Reviews Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Validation and clinical utility of prostate cancer biomarkers
    Journal Article

    Scher, H. I.; Morris, M. J.; Larson, S.; Heller, G.
    Nature Reviews Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prostate cancer in 2011: Hitting old targets better and identifying new targets
    Journal Article

    Chen, Y.; Scher, H. I.
    Nature Reviews Clinical Oncology (2012)

    Fulltext@MSK | Save